The health care bill recently passed by the House imposes big cuts to the underfunded Medicaid program. A new approach is needed, starting with the best ideas of both parties.
- Professor of Medicine, Stanford University
The Orphan Drug Act was enacted 34 years ago to encourage the development of drugs for rare diseases. Drug companies were guaranteed seven years of exclusivity. Then the rush was on to run up prices.
Contact Jay for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Palo Alto
- Article Feed
- Joined

